Dec 2 A U.S. appeals court refused on Wednesday to reconsider its decision invalidating a Sequenom Inc prenatal DNA test patent, a decision that could put in doubt the validity of a wide range of medical and biotechnology patents. The U.S. Court of Appeals for the Federal Circuit in Washington said in June the patent was not eligible for legal protection because it fell under the U.S. Supreme Court's rule against patenting natural phenomena.